Ad is loading...
BEAM
Price
$24.05
Change
-$2.26 (-8.59%)
Updated
Nov 15 closing price
106 days until earnings call
PYXS
Price
$4.19
Change
-$0.09 (-2.10%)
Updated
Nov 15 closing price
122 days until earnings call
Ad is loading...

BEAM vs PYXS

Header iconBEAM vs PYXS Comparison
Open Charts BEAM vs PYXSBanner chart's image
Beam Therapeutics
Price$24.05
Change-$2.26 (-8.59%)
Volume$2.26M
CapitalizationN/A
Pyxis Oncology
Price$4.19
Change-$0.09 (-2.10%)
Volume$793.62K
CapitalizationN/A
BEAM vs PYXS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. PYXS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and PYXS is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BEAM: $24.05 vs. PYXS: $4.19)
Brand notoriety: BEAM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 218% vs. PYXS: 134%
Market capitalization -- BEAM: $1.99B vs. PYXS: $248.98M
BEAM [@Biotechnology] is valued at $1.99B. PYXS’s [@Biotechnology] market capitalization is $248.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • PYXS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -11.12% price change this week, while PYXS (@Biotechnology) price change was -5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

PYXS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.99B) has a higher market cap than PYXS($249M). PYXS YTD gains are higher at: 132.778 vs. BEAM (-11.646). PYXS has higher annual earnings (EBITDA): -65.84M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. PYXS (156M). PYXS has less debt than BEAM: PYXS (20.9M) vs BEAM (165M). BEAM has higher revenues than PYXS: BEAM (353M) vs PYXS (16.1M).
BEAMPYXSBEAM / PYXS
Capitalization1.99B249M800%
EBITDA-162.88M-65.84M247%
Gain YTD-11.646132.778-9%
P/E RatioN/AN/A-
Revenue353M16.1M2,193%
Total Cash1.01B156M646%
Total Debt165M20.9M789%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPYXS
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFIEX15.63-0.06
-0.38%
DFA International Core Equity I
PVEJX18.62-0.12
-0.64%
Principal MidCap Value I J
MNMIX14.73-0.12
-0.81%
Manning & Napier Pro-Blend Mod Term I
HSUCX31.63-0.39
-1.22%
Rational Dynamic Brands C
WAMCX35.33-0.80
-2.21%
Wasatch Ultra Growth

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with CTMX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-2.10%
CTMX - PYXS
39%
Loosely correlated
-9.00%
DNLI - PYXS
38%
Loosely correlated
-11.95%
VKTX - PYXS
38%
Loosely correlated
-7.45%
BEAM - PYXS
37%
Loosely correlated
-8.59%
ABOS - PYXS
36%
Loosely correlated
-8.05%
More